Locust Walk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Locust Walk and buy or sell other stocks, options, and ETFs commission-free!

About LWAC

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). 

CEO
Stephen T. Worland, PhD
CEOStephen T. Worland, PhD
Employees
14
Employees14
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
2012
Founded2012
Employees
14
Employees14

LWAC Key Statistics

Market cap
51.15M
Market cap51.15M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
—
Dividend yield—
Average volume
639.65K
Average volume639.65K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$37.00
52 Week high$37.00
52 Week low
$1.75
52 Week low$1.75
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.